NCT02775773View on ClinicalTrials.gov

Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH

PHASE3CompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Post Partum Haemorrhage
Interventions
DRUG

Tranexamic Acid

2 vials ( =1 gram) of Tranexamic Acid slow intravenous infusion administered within 5 minutes from the delivery (third stage after labor)

DRUG

Oxytocin

2 vials (=10 IU/International Unit) of Oxytocin administered intramuscularly within 5 minutes from the delivery (third stage after labor)

Trial Locations (1)

54100

Department of Ostetricia e Ginecologia-Ospedale delle Apuane, Massa

All Listed Sponsors
lead

Azienda U.S.L. 1 di Massa e Carrara

OTHER

NCT02775773 - Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH | Biotech Hunter | Biotech Hunter